内源性大麻素受体CB2R在阿司匹林加重性呼吸系统疾病中显著表达:一项初步研究
该初步研究前瞻性检测了鼻息肉组织及对照组蝶窦黏膜中内源性大麻素受体的表达,发现阿司匹林加重性呼吸系统疾病(AERD)患者CNR2表达较变应性真菌性鼻窦炎(AFRS)和对照组显著上调,平均增加5.2倍,而CNR1表达无显著差异。免疫组化显示CB1R和CB2R主要定位于表面上皮。提示内源性大麻素系统可能参与AERD的免疫调节。
要点
- AERD患者鼻息肉中CNR2表达较AFRS和对照组显著升高。
- CNR2平均增加5.2倍,CB1R基因CNR1表达无显著组间差异。
- CB1R和CB2R主要定位于鼻黏膜表面上皮。
核心结论
- 内源性大麻素系统可能参与AERD的免疫调节,CB2R转录在AERD鼻息肉中显著增加。
研究设计与样本
- 采用qRT-PCR和免疫组化评估内源性大麻素受体的表达与定位,使用不等方差两组非配对t检验比较组间差异。
主要发现
- AERD患者CNR2表达较AFRS显著上调(p = 0.049),较对照组显著上调(p = 0.047),平均增加5.2倍。
- 对照组与AFRS组间CNR1表达无显著差异。
- 免疫组化显示CB1R和CB2R在所有受试者中主要定位于表面上皮。
局限性
- 需要进一步研究评估该新发现的作用和治疗潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The endocannabinoid system represents a highly conserved, innate signaling network with direct and indirect control of eicosanoid-mediated inflammation. Activation of the type 2 cannabinoid receptor (CB2R) leads to decreased type 2 inflammation and reduced production of arachidonic acid (AA). Given that altered AA metabolism is associated with aspirin-exacerbated respiratory disease (AERD), we hypothesized that expression of the CB2R gene CNR2 is increased in AERD. METHODS: Nasal polyps from consecutive patients undergoing endoscopic sinus surgery for AERD or allergic fungal rhinosinusitis (AFRS) were prospectively evaluated. Control sphenoid mucosa was collected from patients undergoing endoscopic skull base procedures. Expression and localization of endocannabinoid receptors were evaluated by quantitative reverse transcript-polymerase chain reaction (qRT-PCR) and immunohistochemistry. A 2-group unpaired t test with unequal variances was used to evaluate group differences. RESULTS: Thirteen subjects were included in this pilot study, including 5 controls, 5 AFRS patients, and 3 AERD patients. Upregulated expression of CNR2 was detected in subjects with AERD vs both AFRS (p = 0.049) and controls (p = 0.047), with a mean increase of 5.2-fold. No significant differences in expression of the CB1R gene CNR1 were detected between control and AFRS groups. Immunohistochemistry predominantly localized CB1R and CB2R expression to the surface epithelium in all subjects. CONCLUSION: The endocannabinoid system is an emerging immunomodulatory network that may be involved in AERD. This is the first study of CB2R in sinonasal disease, showing significantly increased transcription in nasal polyps from subjects with AERD. Additional study is warranted to further evaluate the contribution and therapeutic potential of this novel finding in chronic rhinosinusitis.
引用
- Corrado A, Battle M, Wise SK, et al. Endocannabinoid receptor CB2R is significantly expressed in aspirin-exacerbated respiratory disease: a pilot study. Int Forum Allergy Rhinol. 2018. PMID: 29897665. doi:10.1002/alr.22163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。